0570.HK

China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted profit also fell by 50% to 60% year-on-year.

The company’s profit totaled 1.4 billion yuan ($191 million) in 2023, according to its latest annual report, meaning last year’s profit will fall to 140 million yuan or even to nil.

The company blamed the big drop on price cuts required by China’s centralized procurement system, as well as intensifying market competition and relatively high costs of medicinal materials. It added that credit, goodwill and plant impairment costs increased during the period. Its profit was also affected by remedial taxes on some of its subsidiaries last year.

Shares of China Traditional Chinese Medicine fell 6.3% to HK$1.92 in Thursday trading after the profit warning’s release.

By Lau Chi HangTo subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Andre Juice sells juice concentrate

Andre Juice’s growth stalls after bumper period

China’s leading maker of apple juice concentrate reported its revenue contracted in the third quarter, ending a period of strong gains in the previous year and a half Key Takeaways:…
Fuyao Glass logs double digit growth

Fuyao Glass looks to new era as its founder bows out

The son of celebrated entrepreneur Cao Dewang has formally taken the helm at the automotive glass giant, just as the firm unveiled upbeat quarterly earnings Key Takeaway: The company logged…